ARTELO BIOSCIENCES, INC. Basic Shares Outstanding (Weighted Average)
ARTELO BIOSCIENCES, INC. (ARTL) reported Basic Shares Outstanding (Weighted Average) of 3.43 million shares for the 3-month period ending 2020-02-29, per its 10-Q filed 2020-04-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2020-04-13
- ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2020-02-29 was 3.43M shares, a 78.64% increase year-over-year.
- ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2019-11-30 was 3.36M shares, a 91.60% increase year-over-year.
- ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2019-08-31 was 3.00M shares, a 376.19% increase year-over-year.
- ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic for the quarter ending 2019-05-31 was 2.06M shares, a 29.28% increase year-over-year.
- ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2019 was 2.17M shares, a 70.05% increase from fiscal 2018.
- ARTELO BIOSCIENCES, INC. weighted average number of shares outstanding, basic for fiscal 2018 was 1.28M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2020-02-29 | 3.43M shares 10-Q · filed 2020-04-13 | 3.39M shares 10-Q · filed 2020-04-13 | 3.26M shares derived: average of 3 quarters · filed 2020-04-13 | 2.96M shares derived: average of 4 quarters · filed 2020-04-13 |
| 2019-11-30 | 3.36M shares 10-Q · filed 2020-01-14 | 3.18M shares derived: average of 2 quarters · filed 2020-01-14 | 2.81M shares derived: average of 3 quarters · filed 2020-01-14 | 2.58M shares derived: average of 4 quarters · filed 2020-04-13 |
| 2019-08-31 | 3.00M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | 2.53M shares derived: average of 2 quarters · filed 2019-12-18 | 2.32M shares derived: average of 3 quarters · filed 2020-04-13 | 2.17M shares 10-K/A · filed 2019-12-18 |
| 2019-05-31 | 2.06M shares 10-Q · filed 2019-07-15 | 1.99M shares derived: average of 2 quarters · filed 2020-04-13 | 1.90M shares 10-Q · filed 2019-07-15 | 1.59M shares derived: average of 4 quarters · filed 2020-04-13 |
| 2019-02-28 | 1.92M shares 10-Q · filed 2020-04-13 | 1.84M shares 10-Q · filed 2020-04-13 | 1.43M shares derived: average of 3 quarters · filed 2020-04-13 | 1.47M shares derived: average of 4 quarters · filed 2020-04-13 |
| 2018-11-30 | 1.75M shares 10-Q · filed 2020-01-14 | 1.19M shares derived: average of 2 quarters · filed 2020-01-14 | 1.33M shares derived: average of 3 quarters · filed 2020-01-14 | |
| 2018-08-31 | 628.97K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-18 | 1.11M shares derived: average of 2 quarters · filed 2019-12-18 | 1.28M shares 10-K/A · filed 2019-12-18 | |
| 2018-05-31 | 1.59M shares 10-Q · filed 2019-07-15 | 1.49M shares 10-Q · filed 2019-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |